| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2024―Sep―17 |
A multicenter, randomized, open-label, placebo-controlled clinical trial of the effect of cetylpyridinium chloride (CPC) mouthwash and on-demand aqueous chlorine dioxide mouthwash on SARS-CoV-2 viral titer in patients with mild COVID-19 |
Daisuke Onozuka, Keiji Konishi, Satoko Takatera, Masahide Osaki, Shougen Sumiyoshi, Yusuke Takahashi, et al. (+3) Shigeto Hamaguchi, Yasuo Imoto, Satoshi Kutsuna |
| 2 |
[GO] |
2022―Sep―20 |
SARS-CoV-2 test outcomes among dentists and dental hygienists with COVID-19-like complaints - A retrospective analysis from the Netherlands |
Fridus A. Van der Weijden, Brechje de Gier, Monique J.C. de Bruin, Cees Valkenburg, Dagmar E. Slot |
| 3 |
[GO] |
2022―Sep―14 |
Use of mouthwash and dentifrice containing an antimicrobial phthalocyanine derivative for the reduction of clinical symptoms of COVID-19: A randomized triple-blind clinical trial |
Marcelo Lupion Poleti, Danielle Gregório, Alisson Gabriel Idelfonso Bistaffa, Karen Barros Parron Fernandes, Fabiano Vieira Vilhena, Paulo Sérgio da Silva Santos, et al. (+4) Andréa Name Colado Simão, Marcell Alysson Batisti Lozovoy, Berenice Tomoko Tatibana, Thais Maria Freire Fernandes |
| 4 |
[GO] |
2022―Mai―08 |
Dental aerosols should not be ignored during the COVID-19 pandemic until proven otherwise. |
Poramate Pitak-Arnnop, Prim Auychai, Andreas Neff |
| 5 |
[GO] |
2021―Dez―24 |
Taste Disorders and Xerostomia are Highly Prevalent in Patients with COVID-19 |
Satheesh Elangovan |
| 6 |
[GO] |
2021―Aug―29 |
QUALITY APPRAISAL OF CLINICAL PRACTICE GUIDELINES ON PROVISION OF DENTAL SERVICES DURING THE FIRST MONTHS OF THE COVID-19 PANDEMIC |
Naira Figueiredo Deana, Carlos Zaror, Andrea Seiffert, Yanela Aravena-Rivas, Patricia Muñoz-Millán, Gerardo Espinoza-Espinoza, et al. (+2) Patricia Pineda, Pablo Alonso-Coello |
| 7 |
[GO] |
2021―Apr―28 |
In vivo evaluation of the virucidal efficacy of Chlorhexidine and Povidone-iodine mouthwashes against salivary SARS-CoV-2. A randomized-controlled clinical trial |
Rola Elzein, Fadi Abdel-Sater, Soha Fakhreddine, Pierre Abi Hanna, Rita Feghali, Hassan Hamad, Fouad Ayoub |
| 8 |
[GO] |
2021―Feb―06 |
Saliva may be considered as reliable tool for diagnosis of COVID-19 when compared to nasopharynx or throat swabs |
Ahmed Yaseen Alqutaibi, Musab Hameed Saeed, Afaf Noman Aboalrejal |
| 9 |
[GO] |
2021―Jan―25 |
Acute Loss of Smell or Taste Without Nasal Blockage Should Raise Suspicion for COVID-19 Infection |
Satheesh Elangovan |
| 10 |
[GO] |
2020―Sep―22 |
Fever and other clinical indicators may fail to detect COVID-19 infected individuals |
Kenneth Markowitz, Maxine Strickland, Ai Huang |
